TABLE 1.
Normal range |
Gardos-HX (n = 15) |
Piezo1-HX (n = 79) |
|||||
Splenectomy |
Splenectomy |
||||||
Yes | No | p | Yes | No | p | ||
N | 7 | 8 | 8 | 71 | |||
Hb (g/L) | 120–160 (female) 130–180 (male) | 918.7 | 1121.1 | <0.05 | 123.717 | 124.812 | 0.24 |
Reticulocyte (G/L) | 20–120 | 34115 | 17462 | 0.07 | 284135 | 307100 | 0.78 |
MCV | 80–100 | 1074.2 | 922.7 | <0.001 | 10311 | 967.1 | 0.25 |
rMCV (fL) | 92–120 | 96.85.3 | 93.63.8 | 0.27 | 11410 | 1117 | 0.66 |
mMCHC (g/L) | 310–360 | 34312 | 35323 | 0.5 | 36537 | 37021 | 0.84 |
rMCHC (g/L) | 270–330 | 37213 | 36417 | 0.1 | 30529 | 33418 | 0.1 |
ΔMCV (fL) | – | −5.81.9 | 3.52.5 | <0.001 | 16.36 | 19.66 | 0.05 |
ΔMCHC (g/L) | – | 289 | 106 | <0.001 | −65.414 | −52.48.6 | 0.21 |
In Gardos-HX, ΔMCV was significantly lower and MCV and ΔMCHC were significantly higher in splenectomized subjects, in splenectomized or non-splenectomized cases, the differential indices remained discriminant for Gardos or Piezo1-HX.